D58N (p.Asp58Asn) variant of IRS2 (Insulin receptor substrate 2)
D58N (p.Asp58Asn) in IRS2 (Insulin receptor substrate 2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.26 / 1. The record also includes population frequency data and structural context.
D58N (p.Asp58Asn) variant details
- p.Asp58Asn
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.257
- REVEL 0.03
- CADD 17.50
- PolyPhen-2 0.14
- SIFT 0.20
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available